Back

Macrophages redeploy functional cancer cell surface proteins following phagocytosis

Volk, R. F.; Casebeer, S. W.; Condon, A. C.; Zirak, B.; Manon, N.; Irkliyenko, I.; Liao, H.; Tao, S.; Pollini, T.; Ramani, V.; Maker, A.; Fidler, T.; Goodarzi, H.; Zaro, B. W.

2024-09-25 immunology Community evaluation
10.1101/2024.09.23.613776 bioRxiv
Show abstract

Macrophage-mediated phagocytosis is a vital innate immune process altered in cancer. We show here that tumor-associated macrophages (TAMs) redeploy intact cell surface proteins from cancer cells to their own cell surface. We initially observed the canonical epithelial cancer surface marker EpCAM on the surface of TAMs in primary human solid tumors but not paired peripheral blood macrophages. In a murine model of metastatic breast cancer, we also observed EpCAM on the surface of primary TAMs that have phagocytosed breast cancer cells. In a model of a myeloproliferative neoplasm, we again found engulfed cell-derived surface proteins on the surface of macrophages following phagocytosis. A co-culture system and proteomics assay that tags proteins based on their cell-of-origin revealed hundreds of cell surface proteins synthesized in cancer cells are present and fully intact on the surface of macrophages following phagocytosis. Using a biotin transfer assay, we determined that these proteins were on the surface of the cancer cell prior to redeployment by the macrophage following phagocytosis. Furthermore, macrophages that redeploy a neutral amino acid transporter correspondingly show increased transport of an unnatural amino acid substrate. Widespread acquisition of proteins from engulfed cells may contribute to two critical TAM phenotypes: the inability to phagocytose and reprogrammed metabolism.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Cell
370 papers in training set
Top 0.1%
33.3%
2
Cell Reports
1338 papers in training set
Top 2%
10.2%
3
Nature Communications
4913 papers in training set
Top 17%
10.2%
50% of probability mass above
4
eLife
5422 papers in training set
Top 11%
6.9%
5
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 15%
4.6%
6
Nature
575 papers in training set
Top 7%
3.6%
7
Immunity
58 papers in training set
Top 1%
3.6%
8
Cell Systems
167 papers in training set
Top 5%
2.8%
9
Science Advances
1098 papers in training set
Top 9%
2.8%
10
Science Immunology
81 papers in training set
Top 1%
1.5%
11
Cancer Cell
38 papers in training set
Top 1%
1.3%
12
Cell Chemical Biology
81 papers in training set
Top 2%
1.2%
13
Science
429 papers in training set
Top 16%
1.2%
14
Cancer Research
116 papers in training set
Top 3%
1.2%
15
Journal of Experimental Medicine
106 papers in training set
Top 3%
0.9%
16
EMBO reports
136 papers in training set
Top 5%
0.9%
17
Nature Biotechnology
147 papers in training set
Top 7%
0.8%
18
PLOS Biology
408 papers in training set
Top 23%
0.7%
19
Molecular Cell
308 papers in training set
Top 11%
0.5%
20
Heliyon
146 papers in training set
Top 9%
0.5%
21
Nature Immunology
71 papers in training set
Top 2%
0.5%
22
Journal of Cell Biology
333 papers in training set
Top 6%
0.5%
23
iScience
1063 papers in training set
Top 40%
0.5%
24
Blood Advances
54 papers in training set
Top 2%
0.5%
25
Genes & Development
90 papers in training set
Top 2%
0.5%